XOMA Corporation ( XOMAP) - Stock Earnings
XOMAP Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 14.1 million USD | 532000 USD |
| 2025Q4 | 6.1 million USD | 1.4 million USD |
| 2026Q1 | 4.5 million USD | 12.3 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
XOMAP Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -40.8 million USD | 4.8 million USD |
| 2024 | -13.8 million USD | 28.5 million USD |
| 2025 | 31.7 million USD | 52.1 million USD |
| 2026 Est. | — | — |
XOMAP
Price: $25.51
Dividend Yield: 8.47%
Forward Dividend Yield: 8.45%
Payout Ratio: 215.41%
Dividend Per Share: 2.16 USD
Earnings Per Share: 1.00 USD
P/E Ratio: 25.27
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1300
Market Capitalization: 307.1 million
Average Dividend Frequency: 4
Years Paying Dividends: 6